featured
Ruxolitinib for Glucocorticoid-Refractory Chronic Graft-Versus-Host Disease
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
The New England Journal of Medicine
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Ruxolitinib for Glucocorticoid-Refractory Chronic Graft-Versus-Host Disease
N. Engl. J. Med 2021 Jul 15;385(3)228-238, R Zeiser, N Polverelli, R Ram, SK Hashmi, R Chakraverty, JM Middeke, M Musso, S Giebel, A Uzay, P Langmuir, N Hollaender, M Gowda, T Stefanelli, SJ Lee, T Teshima, F LocatelliFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.